CasLoc logo
All Cases PTAB Litigations UPC Oppositions

FRESENIUS KABI USA, LLC vs. AstraZeneca AB

Explore the PTAB proceeding IPR2017-01912 filed by FRESENIUS KABI USA, LLC on 2017-08-04. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-01912

Filing Date

2017-08-04

Accorded Filing Date

2017-08-04

Institution Decision Date

2017-12-11

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

โ€”

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 13602667
Respondent Patent Number 8466139
Legal Expiration Date
2032-09-04 Active (5.8 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor John R. Evans et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Institution Denied 2017-12-11
Decision - Denying Institution of Inter Partes Review
37 CFR 1.132, 35 USC 314, 37 CFR 42.100, 37 CFR 42.108

Address and Attorney/Agent Information

215 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER - LLP
Customer Number 22852
Address 901 NEW YORK AVENUE, NW, WASHINGTON, DC, 20001-4413, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
28165 Charles Lipsey +1 571-203-2755
30413 John Paul +1 202-408-4109
30415 Richard Racine +1 202-408-4038
31744 Richard Burgujian +1 571-203-2790
32120 Barbara Mccurdy +1 202-408-4000 X4047
32409 Bryan Diner +1 202-408-4000
32824 John Jakes +1 202-408-4000
33234 Michael Flibbert +1 202-408-4000

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 4 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 9 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): GB ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (13 found):
PTAB: 9 U.S. Courts: 4
USPTO PTAB Trial 2017-08-04
IPR2017-01910

Fresenius Kabi USA,LLC v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2017-08-04
IPR2017-01913

Fresenius Kabi USA, LLC v. AstraZeneca AB

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00900

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00905

InnoPharma Licensing LLC et al. v. AstraZeneca AB

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00904

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2016-06-29
IPR2016-01325

Mylan Pharmaceuticals Inc. et al. v. AstraZeneca AB et al.

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2016-06-29
IPR2016-01326

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01324

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (7456160)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01316

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Terminated-Settled
U.S. District Court 2017-12-14
1:17-cv-01795

AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC

Asserted Patent
Status: DED
U.S. District Court 2016-08-05
1:16-cv-00669

AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC

Asserted Patent
Status: DED
U.S. District Court 2014-06-03
1:14-cv-03547

ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.

Asserted Patent
Status: NJD
U.S. District Court 2010-01-07
1:10-cv-00018

AstraZeneca Pharmaceuticals LP v. Teva Parenteral Medicines Inc.

U.S. Family Sibling (["US6774122", "US7456160"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
11

Notice of Refund Paper

2018-02-02 FILING PARTY: BOARD
10

Petitioner's Refund Request Paper

2018-01-24 FILING PARTY: PETITIONER
9

Decision - Denying Institution of Inter Partes Review Paper

2017-12-11 FILING PARTY: BOARD
3002

Amendment to the Claims, Patent Appl. No. 12/285,887 Exhibits

2017-12-11 FILING PARTY: BOARD
2146

Rose 1985 Exhibits

2017-11-16 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc